Bio Venture Amyris Files Ch. 11 With $1.1B In Debt

Synthesized biologicals producer Amyris Inc. filed for Chapter 11 protection in Delaware bankruptcy court Thursday, saying it needs to reorganize and sell off non-core businesses in the face of more than...

Already a subscriber? Click here to view full article